Portfolio company
Insilico Medicine
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
This company develops artificial intelligence platforms for drug discovery and design to serve pharmaceutical and biotechnology organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Isomorphic Labs
This company develops artificial intelligence platforms for drug discovery and design to serve pharmaceutical and biotechnology businesses.
Atomic AI
This company develops artificial intelligence platforms for RNA-targeted drug discovery to assist biotechnology and pharmaceutical organisations with medicine development.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Aqemia
This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.
Ingenix
This company develops an artificial intelligence system that integrates biological data to support drug development decisions for pharmaceutical and biotechnology organisations.
DeepMirror AI
This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.
Ingenix.ai
This company develops artificial intelligence software for simulating clinical trials and predicting drug efficacy to assist pharmaceutical and biotechnology organisations.
Envisagenics
This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.
